Owner Scorecard


← All companies ← ONIT Manual ONT → ← OABI Life Sciences Tools & Services PACB →

ONMD, OneMedNet Corp

Life Sciences Tools & Services diversified UnprofitableDistress / turnaround

OneMedNet is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data.

OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the life sciences field offering direct access to clinical images and the associated contextual patient record.

OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners case selection protocols and paves the way for Real World Evidence (as defined below).

Latest annual: FY2025 10-K
ONMD · OneMedNet Corp
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$1M
+111.4% YoY · 6% 3-yr CAGR
Vital signs · TTM
Cash & investments $233K
Cash burn · annual $7M
Runway 0 mo

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock.
What moves the needle
Operating margin has run around −711% through the cycle on a −37% gross margin, the operating line deeply negative — so the lever is the path to a margin at all: revenue growth against the cost curve and the cash runway, not the level of a margin that isn't there yet. Stock-based pay runs about 144% of sales, a real and recurring claim on owners that the GAAP margin understates. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2022–2025

realized figures from each filing · older years to the left
2022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$1M$1M$643K$1M$1MRevenueRevenue
−31%−13%−44%−37%−50%Gross marginGross mgn
417%347%n/m469%493%SG&A / revenueSG&A/rev
138%202%228%111%112%R&D / revenueR&D/rev
($8M)($7M)($10M)($10M)($10M)Operating incomeOp. inc.
−669.1%−671.2%n/m−711.3%−758.3%Operating marginOp. mgn
($30M)($34M)($10M)($3M)($3M)Net incomeNet inc.
Cash flow & returns
($5M)($5M)($7M)($8M)($7M)Operating cash flowOp. cash
$25K$28K$57K$65K$64KDepreciationDeprec.
$24M$27M$2M($7M)($6M)Working capital & otherWC & other
$58K$44K$51K$13K$10KCapexCapex
5.0%4.3%7.9%1.0%0.8%Capex / revenueCapex/rev
($5M)($5M)($7M)($8M)($7M)Owner earningsOwner earn.
−412.9%−473.6%n/m−553.1%−546.4%Owner earnings marginOE mgn
($5M)($5M)($7M)($8M)($7M)Free cash flowFCF
−412.9%−473.6%n/m−553.1%−546.4%Free cash flow marginFCF mgn
Balance sheet
$271K$47K$172K$585K$233KCash & investmentsCash+inv
$19K$152K$213K$495K$697KReceivablesReceiv.
$1M$5M$6M$3M$4MAccounts payablePayables
($1M)($5M)($6M)($3M)($3M)Operating working capitalOper. WC
$391K$365K$4M$2M$1MCurrent assetsCur. assets
$26M$14M$19M$5M$5MCurrent liabilitiesCur. liab.
0.0×0.0×0.2×0.4×0.3×Current ratioCurr. ratio
$1M$464K$4M$2M$2MTotal assetsAssets
$2M$465K$12M$1M$2MTotal debtDebt
$1M$418K$12M$609K$1MNet debt / (cash)Net debt
-19.1×-623.0×-65.3×-144.3×-217.3×Interest coverageInt. cov.
($26M)($13M)($16M)($3M)($4M)Shareholders’ equityEquity
161.8%144.5%97.7%149.5%171.1%Stock comp / revenueSBC/rev
Per share
7.9M7.3M28.1M44.5M55.3MShares out (diluted)Shares
$0.15$0.14$0.02$0.03$0.02Revenue / shareRev/sh
$-3.83$-4.65$-0.36$-0.06$-0.06EPS (diluted)EPS
$-0.60$-0.66$-0.25$-0.17$-0.13Owner earnings / shareOE/sh
$-0.60$-0.66$-0.25$-0.17$-0.13Free cash flow / shareFCF/sh
$0.01$0.01$0.00$0.00$0.00Cap. spending / shareCapex/sh
$-3.32$-1.85$-0.57$-0.07$-0.07Book value / shareBVPS

Share counts before 2023 are restated ×2 for a stock split, so per-share figures sit on one basis.

The diluted share count moved ×3.86 into 2024 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

The diluted share count moved ×1.59 into 2025 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
3-yr5-yr
Revenue / share−40.5%/yr−40.5%/yr (3-yr)
Capital spending / share−65.8%/yr−65.8%/yr (3-yr)

The record, charted

FY2022–2025

Each measure over its full record; the current point and the worst year marked. Share counts on the current split basis.

Share count
45Mpeak FY2025
Gross margin
−37%low FY2024

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

($8M)owner earningsvs.($3M)net incomelow FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business reported a $3M loss but ($8M) of owner earnings: $5M less than the profit line, taken out by capital spending and the timing of cash.

FY2025FY2024FY2023FY2022
Reported net income($3M)($10M)($34M)($30M)
Depreciation & amortizationnon-cash charge added back+$65K+$57K+$28K+$25K
Stock-based compensationreal costnon-cash, but a real cost+$2M+$628K+$1M+$2M
Working capital & othertiming of cash in and out, other non-cash items−$7M+$2M+$27M+$24M
Cash from operations($8M)($7M)($5M)($5M)
Capital expenditurecash put back in to keep running and to grow−$13K−$51K−$44K−$58K
Owner earnings($8M)($7M)($5M)($5M)
Owner-earnings marginowner earnings ÷ revenue-553%-1089%-474%-413%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $2M), owner earnings is nearer ($10M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →
Material weakness in financial controls
“We are in the process of remediating the identified material weaknesses in our internal controls, but we are unable at this time to estimate when the remediation efforts will be completed.”

The figures below are only as sound as the controls that produced them. read the note →

Will it survive?

  • Does not cover its interest
    Operating income ($10M) ÷ interest expense $67K
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net debt against an operating loss
    Cash $585K − debt $2M
    What this means

    Netting $585K of cash and short-term investments against $2M of debt leaves $915K owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Negative, funded by others
    DSO 133 + DIO 0 − DPO 627 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. A negative cycle is a quiet moat: suppliers and customers fund the operation (Buffett's “float”), the company grows on other people's money. (Little or no inventory, a services / asset-light model, so the inventory leg is ~0.)

Is it a good business?

  • Not meaningful here
    Invested capital ($2M) = debt $2M + equity ($3M) − cash
    Industry peers: median 8%
    What this means

    Invested capital is near zero or negative, usually years of buybacks pulling equity down. ROIC explodes or flips sign and stops meaning anything. Judge this one on Owner Earnings instead.

  • Consumes cash through the cycle
    4-yr median margin, range -1089%–-413%; latest ($8M) = operating cash ($8M) − maintenance capex $13K
    Industry peers: median 4%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -553% of revenue this year, a -553% median across 4 years. Treating stock comp as the real expense it is (less $2M of SBC) leaves ($10M).

  • Loss, and burning cash
    Net income ($3M) · cash from operations ($8M)

    In the filing’s words The filing discloses a material weakness in its financial controls — the reported numbers here, and the record built on them, are only as reliable as the controls that produced them.

    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.20×
    Harvesting
    Capex $13K ÷ depreciation $65K
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 0 of 3 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $1M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Miss
    Current ratio ≥ 2× · 0.43×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $2M vs ($3M) WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.29/share (latest year $-0.05), the averaged base the calculator's gate runs on, and book value is $-0.05/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2022–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 0 of 4
    What this means

    Lost money in 4 year(s), look at what happened there before trusting the average.

  • Operating margin −670% → −1103% (2-yr avg ends)
    What this means

    Through the cycle the operating margin slipped — about −670% early to −1103% lately, median −711% — competition or costs are biting in.

  • Worst year 2024 · −1493.8% op. margin
    What this means

    Operations went underwater in 2024, understand why before trusting the good years.

Does AI threaten the moat?

Moderate contestability

AI is likely to reshape costs and some products here without clearly contesting or sparing the core moat; how the company itself frames it is the tell.

In its own filing Framed as a capability

The filing positions AI as something the company uses, not something it fears.

“Today, life science companies, including pharmaceutical companies, artificial intelligence ("AI") developers, medical device businesses, and clinical research organizations, share the same widespread challenge in obtaining insight-rich, high-quality patient data that explicitly m…”

The question is whether a moat the record shows as durable outlasts a technology that lowers the cost of part of what the firm sells. The durability is read in the record above, the filing's own framing of AI beside it; the industry label decides nothing on its own.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$1M
  • Cash & short-term investments$233K
  • Receivables$697K
  • Other current assets$530K
Current liabilities$5M
  • Debt due within a year$837K
  • Accounts payable$4M
  • Other current liabilities$577K
Current ratio0.27×all current assets ÷ what's due · Graham looked for 2×
Quick ratio0.27×stricter: inventory excluded
Cash ratio0.04×strictest: cash alone against what's due
Working capital($4M)the cushion left after near-term bills
Debt due this year vs. cash$837K due · $233K cash cash alone won't cover the maturities; it leans on refinancing or operating cash · both figures from the Mar 31, 2026 balance sheet
Cash runway0.0 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago−29.9%the freshest read on whether the business is still growing
Current ratio, recent quarters0.0× → 0.3×
Deeper floors
Tangible book value($4M)equity stripped of goodwill & intangibles
Net current asset value($4M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$1Mno operating-lease liability tagged this quarter, so debt alone
Deferred revenue$679Kcustomer cash collected before delivery; operating float

From the company's latest filing.

Management, ownership & pay

From the proxy: how much of the business the people running it own, and how they are paid.

  • Stock-based compensation$2M

    The slice of the business handed to employees in shares this year, 150% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why OneMedNet Corp is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2022–2025.

1 of the 3 tests turned up something to look into; the other 2 came back clean.

  • Look hereDid receivables and inventory outpace sales?2% → 53% of sales

    Receivables and inventory grew from $19K to $697K while revenue grew 14%: working capital is climbing faster than sales (2% of revenue then, 53% now). That can mean customers paying slower, stock building up, or revenue pulled forward. The filing's cash-flow and receivables notes say which.

And these came back clean
  • Did debt outgrow the business?
  • Are "one-time" charges a yearly habit?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Life Sciences Tools & Services

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
MEDPMedpace Holdings$2.5B17.6%27%22%
NEONeoGenomics Inc.$727M42%-8.5%-7%-4%
MGMistras Group Inc$724M32%2.9%3%4%
WLDNWilldan Group Inc.$682M35%4.9%8%4%
EXPOExponent$582M20.8%44%22%
NRCNRC Health$137M29.3%47%21%
OABIOmniAb Inc.$19M-203.2%-18%-35%
ONMDOneMedNet Corp$1M-34%-691.3%-513%
Group median33%3.9%4%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

OneMedNet Corp is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered0%/yr’22→’25

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−546%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "OneMedNet Corp (ONMD), the owner's record," https://ownerscorecard.com/c/ONMD, data as of 2026-07-09.

Manual order: ← ONIT its page in the Manual ONT →

Industry order: ← OABI the Life Sciences Tools & Services chapter PACB →